ALBANY, N.Y., Jul 12, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO) announced today the global expansion of its Smart Port CT family of power-injectable ports, featuring its patented Vortex (R) port technology - to include low-profile and mini models for repeated treatments such as

ALBANY, N.Y., Jun 17, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will report its fiscal 2010 fourth quarter and full year financial

ALBANY, N.Y., May 20, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ: ANGO) today announced the appointment of Lynda Wallace, 47, as Senior Vice President of Business Development. In this capacity, Ms. Wallace will lead AngioDynamics' business development and strategic planning activities and join

<i><b>Company Now Offers Full Line of Peripherally Inserted Central
Catheters</b></i>
<br />

<i><b>New Centros Catheter Features an Enhanced Tip Design to Optimize
Blood Flow</b></i>
<br />

ALBANY, N.Y., May 04, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the Bank of America Merrill Lynch Health Care

<i>Segment expected to highlight advantages of new gold-tip NeverTouch® laser fiber</i>

ALBANY, N.Y., Apr 27, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the Deutsche Bank 35 th Annual Health Care Conference

<i>Seven Medical Centers in Europe to Participate in Clinical Trial</i>
<br />

<ul>
<li class="bwlistitemmarginbottom">
<i><b>Net Sales Increase 6% to $52.2 million</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>NanoKnife</b></i>^{<i><b>(R)</b></i>}<i><b> IRE System Net
Sales of $724,000</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>Net Income of $3.3 Million, or $0.13 EPS</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>Operating Cash Flow of $11.4 Million</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>Company Reiterates Fiscal 2010 Guidance</b></i>
</li>
<li class="bwlistitemmarginbottom">
<i><b>Conference Call Begins Today at 4:30 p.m. Eastern Time</b></i>
</li>
</ul>

Location leverages Albany International Airport, Resources of New York's Tech Valley

<i><b>Book Explores IRE Technology Featured in AngioDynamics' NanoKnife
System</b></i>
<br />

QUEENSBURY, N.Y., Mar 15, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO) , a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it has changed the date that it will report its fiscal 2010 third

QUEENSBURY, N.Y., Mar 11, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO) , a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will report its fiscal 2010 third quarter financial results on

More on the procedure can be found at <A HREF="http://www.venacure-evlt.com">www.venacure-evlt.com</A&gt;

QUEENSBURY, N.Y., Jan 07, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the 28th Annual J.P.

<ul><li class="bwlistitemmarginbottom"><i><b>Net Sales Increase 10% to $53.5 Million</b></i></li><li class="bwlistitemmarginbottom"><i><b>NanoKnife</b></i>^{<i><b>(R)</b></i>}<i><b> IRE System Net
Sales of $700,000</b></i></li><li class="bwlistitemmarginbottom"><i><b>Net Income Increase of 8% to $3.1 Million, or $0.13 EPS</b></i></li><li class="bwlistitemmarginbottom"><i><b>Operating Cash Flow of $11.2 Million</b></i></li><li class="bwlistitemmarginbottom"><i><b>Conference Call Begins Today at 4:30 p.m. Eastern Time</b></i></li></ul>

<i><b>New Options Provide Physicians with Comprehensive Product Line
from Single Source</b></i><br />

<i><b>New Catheter Completes Drainage Product Portfolio</b></i><br />

QUEENSBURY, N.Y., Dec 15, 2009 (BUSINESS WIRE) -- AngioDynamics (NASDAQ:ANGO) , a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will report its fiscal 2010 second quarter financial results on